A review indicates obesity may amplify pathophysiology in HFrEF rather than acting as a primary cause, though weight loss data remain inconclusive.

A new Scientific Statement from the Heart Failure Society of America (HFSA) challenges longstanding ambiguity in the classification and treatment of heart failure with mildly reduced ejection fraction ...

EAT index measured by CMR may identify high-risk HFpEF patients and predict outcomes. Learn more about its role in risk ...

People with mildly reduced ejection fraction, a distinct group with unique needs, account for nearly one-quarter of HF cases.

Objective: To provide an overview of heart failure with preserved ejection fraction (HFPEF), as well as its pathophysiology, diagnosis, and clinical evidence regarding its pharmacologic management.

SPIRIT-HF missed its primary composite endpoint at 2 years, with higher observed event rates on spironolactone versus placebo ...

LV myocardial strain reference values from CT reveal sex differences in healthy adults. Learn how this could refine cardiac ...